| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.17 | 0.2 |